Viewing Study NCT04334057


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2025-12-25 @ 4:04 PM
Study NCT ID: NCT04334057
Status: COMPLETED
Last Update Posted: 2025-08-29
First Post: 2020-04-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module